DoseRoutine Research Team
Compiles compound entries from primary literature, FDA labels and regulatory records
The DoseRoutine Research Team compiles every library entry from primary literature, regulatory documents and manufacturer labels, and records the citation behind each factual claim.
Who we are
The DoseRoutine Research Team is the in-house group that builds and maintains the compound library, the interaction rule set and the long-form guides behind DoseRoutine. Pages are published under the team rather than a single writer because each one is assembled from a shared, versioned data set that several people maintain.
How an entry is built
We start from primary literature indexed in PubMed, then add regulatory and label data from FDA, DailyMed and EMA records, and established reference databases for pharmacokinetic basics such as half-life, route and metabolic pathway. Each factual claim is stored with the citation it came from, so the source can be shown on the page.
What we will not publish
No invented studies, no fabricated clinician credentials, no personalized dose recommendations. Half-life and pharmacokinetic values are labeled by evidence tier — human clinical, preclinical, estimated, or not applicable — and unsupported estimates are left blank instead of guessed.
Review and corrections
Before publication, entries are checked by our editorial reviewer against the cited sources. Reported errors are verified and fixed, and the page's last-updated date changes when the content does.
Areas covered
- Compound library entries
- Dosing and timing guides
- Interaction rules
- Pharmacokinetic data
- Nutrition and food data
- Product and label research
Not medical advice. DoseRoutine content is educational reference material. Confirm dosing and safety decisions with a licensed clinician.
Spotted an error? support@doseroutine.com · Editorial & review policy · Sources & methodology
Profile last reviewed September 10, 2026.